Caffeine Use by Children: The Quest for Enhancement

References

• Advocare. Product facts and ingredients: KickStart SPARK™. 2005, http://www.advocare.com/store/images/labels/k2083.pdf Retrieved October 12, 2005, from
   Google Scholar
• American Academy of Pediatrics. Policy statement: Use of performance enhancing substances. Pediatrics 2005; 115: 1103–1106
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Author, Washington, DC 1994
   Google Scholar
• Babcock Q., Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. Journal of American College Health 2000; 49: 143–145
   PubMed Web of Science ®Google Scholar
• Bahrke M. S., Yesalis C. E., Brower K. J. Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents. Child and Adolescent Psychiatric Clinics of North America 1998; 7: 821–838
   PubMed Web of Science ®Google Scholar
• Bernstein G. A., Carroll M. E., Thuras P. D., Cosgrove K. P., Roth M. E. Caffeine dependence in teenagers. Drug and Alcohol Dependence 2002; 66: 1–6
   PubMed Web of Science ®Google Scholar
• Bradley J. R., Petree A. Caffeine consumption, expectancies of caffeine-enhanced performance, and caffeinism symptoms among university students. Journal of Drug Education 1990; 20: 319–328
   PubMed Web of Science ®Google Scholar
• Broderick P., Benjamin A. B. Caffeine and psychiatric symptoms: A review. Journal of the Oklahoma State Medical Association 2004; 97: 538–542
   PubMedGoogle Scholar
• Canadian Centre for Drug-Free Sport. National School Survey on Drugs and Sport. Ottawa, OntarioCanada 1993
   Google Scholar
• Cole K. J., Costill D. L., Starling R. D., Goodpaster B. H., Trappe S. W., Fink W. J. Effect of caffeine ingestion on perception of effort and subsequent work production. International Journal of Sport Nutrition 1996; 6: 14–23
   PubMed Web of Science ®Google Scholar
• Commonwealth of Australia. Australia New Zealand Food Standards Code. Standard 2.6.4: Formulated Caffeinated Beverages. 2006
   Google Scholar
• Delbeke F. T., Debackere M. Caffeine: Use and abuse in sports. International Journal of Sports Medicine 1984; 5: 179–182
   PubMed Web of Science ®Google Scholar
• Forman E. S., Dekker A. H., Javors J. R., Davison D. T. High-risk behaviors in teenage male athletes. Clinical Journal of Sports Medicine 1995; 5: 36–42
   PubMed Web of Science ®Google Scholar
• Forman J., Aizer A., Young C. R. Myocardial infarction resulting from caffeine overdose in an anorectic woman. Annals of Emergency Medicine 1997; 29: 178–180
   Google Scholar
• Garriott J. C., Simmons L. M., Poklis A., Mackell M. A. Five cases of fatal overdose from caffeine-containing “look-alike” drugs. Journal of Analytical Toxicology 1985; 9: 141–143
   PubMed Web of Science ®Google Scholar
• Gilliland K., Andress D. Ad lib caffeine consumption, symptoms of caffeinism, and academic performance. American Journal of Psychiatry 1981; 138: 512–514
   PubMed Web of Science ®Google Scholar
• Holmgren P., Nordén-Pettersson L., Ahlner J. Caffeine fatalities—Four case reports. Forensic Science International 2004; 139: 71–73
   PubMed Web of Science ®Google Scholar
• Jafri S. H., Cook J. W., Reed R. R., Beebe D. K. Acute onset of bilateral myoclonus in a 16-year-old female. Journal of the Mississippi State Medical Association 2004; 45: 169–172
   Google Scholar
• Kerrigan S., Lindsey T. Fatal caffeine overdose: Two case reports. Forensic Science International 2005; 153: 67–69
   PubMed Web of Science ®Google Scholar
• Klingler W., Heffron J. J., Jurkat-Rott K., O'sullivan G., Alt A., Schlesinger F., Bufler J., Lehmann-Horn F. 3,4-Methylenedioxymethamphetamine (Ecstasy) activates skeletal muscle nicotinic acetylcholine receptors. Journal of Pharmacology and Experimental Therapeutics 2005; 314: 1267–1273
   PubMedGoogle Scholar
• Krahn D. D., Hasse S., Ray A., Gosnell B., Drewnowski A. Caffeine consumption in patients with eating disorders. Hospital and Community Psychiatry 1991; 42: 313–315
   PubMedGoogle Scholar
• Lambert G. H., Schoeller D. A., Kotake A. N., Flores C., Hay D. The effect of age, gender, and sexual maturation on the caffeine breath test. Developmental Pharmacology and Therapeutics. 1986; 9: 375–388
   Google Scholar
• Lande R. G. Caffeine-related psychiatric disorders. 2005, http://www.emedicine.com/med/topic3115.htm Retrieved November 11, 2005, from
   Google Scholar
• Leon M. R. Effects of caffeine on cognitive, psychomotor, and affective performance of children with attention-deficit/hyperactivity disorder. Journal of Attention Disorders 2000; 4: 27–47
   Google Scholar
• Leson C. L., McGuigan M. A., Bryson S. M. Caffeine overdose in an adolescent male. Journal of Toxicology and Clinical Toxicology 1988; 26: 407–415
   PubMed Web of Science ®Google Scholar
• Lutz E. G. Restless legs, anxiety and caffeinism. Journal of Clinical Psychiatry 1978; 39: 693–698
   PubMed Web of Science ®Google Scholar
• McCabe S. E., Teter C. J., Boyd C. J. The use, misuse and diversion of prescription stimulants among middle and high school students. Substance Use & Misuse 2004; 39: 1095–1116
   PubMed Web of Science ®Google Scholar
• McGee M. B. Caffeine poisoning in a 19-year-old female. Journal of Forensic Science 1980; 25: 29–32
   PubMed Web of Science ®Google Scholar
• McNamara R., Kerans A., O'Neill B., Harkin A. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA (“Ecstasy”) and MDA (“Love”). Neuropharmacology 2006; 50: 69–80
   Google Scholar
• Mehlman M. J. Cognition-enhancing drugs. Milbank Quarterly 2004; 82: 483–506
   PubMed Web of Science ®Google Scholar
• Mehlman M. J. Cognition-enhancing drugs: An ethical analysis. Paper presented at the XIXth European Conference on Philosophy of Medicine and Health Care, BarcelonaSpain, August, 2005
   Google Scholar
• Miller M. C. What are caffeine's psychological benefits and risks?. Harvard Mental Health Letter 2005; 22: 8
   Google Scholar
• Mitchell P. J., Redman J. R. Effects of caffeine, time of day and user history on study-related performance. Psychopharmacology (Berlin) 1992; 109: 121–126
   PubMed Web of Science ®Google Scholar
• Musser C. J., Ahmann P. A., Theye F. W., Mundt P., Broste S. K., Mueller-Rizner N. Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children. Journal of Developmental and Behavioral Pediatrics 1998; 19: 187–192
   PubMed Web of Science ®Google Scholar
• Nagesh R. V., Murphy K. A., Jr. Caffeine poisoning treated by hemoperfusion. American Journal of Kidney Disease 1988; 12: 316–318
   PubMed Web of Science ®Google Scholar
• National Collegiate Athletic Association. NCAA banned-drug classes 2006–2007. 2006, http://www.ncaa.org/membership/ed_outreach/health-safety/drug_testing/banned_drug_classes.pdf Retrieved June 19, 2006, from
   Google Scholar
• National Federation of State High School Associations. Sports medicine: NFHS position statement on supplements. November, 2003, www.nfhs.org Retrieved October 12, 2005, from
   Google Scholar
• Oberstar J. V., Bernstein G. A., Thuras P. D. Caffeine use and dependence in adolescents: One-year follow-up. Journal of Child and Adolescent Psychopharmacology 2002; 12: 127–135
   PubMed Web of Science ®Google Scholar
• Parrott A. C. Is Ecstasy MDMA? A review of the proportion of Ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology (Berlin) 2004; 173: 234–241
   PubMed Web of Science ®Google Scholar
• Rapoport J. L., Elkins R., Neims A., Zahn T., Berg C. J. Behavioral and autonomic effects of caffeine in normal boys. Developmental Pharmacology and Therapeutics 1981; 3: 74–82
   PubMedGoogle Scholar
• Rapoport J. L., Jensvold M., Elkins R., Buchsbaum M. S., Weingartner H., Ludlow C., Zahn T. P., Berg C. J., Neims A. H. Behavioral and cognitive effects of caffeine in boys and adult males. Journal of Nervous and Mental Disease 1981; 169: 726–732
   PubMedGoogle Scholar
• Rowland A. S., Lesesne C. A., Abramowitz A. J. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): A public health view. Mental Retardation and Developmental Disabilities Research Reviews 2002; 8: 162–170
   PubMedGoogle Scholar
• Schifano F., Oyefeso A., Webb L., Pollard M., Corkery J., Ghodse A. H. Review of deaths related to taking Ecstasy, England and Wales, 1997–2000. British Medical Journal 2003; 326: 80–81
   PubMed Web of Science ®Google Scholar
• Shaul P. W., Farrell M. K., Maloney M. J. Caffeine toxicity as a cause of acute psychosis in anorexia nervosa. Journal of Pediatrics 1984; 105: 493–495
   PubMed Web of Science ®Google Scholar
• Shioda K., Nisijima K., Nishida S., Kato S. Possible serotonin syndrome arising from an interaction between caffeine and serotonergic antidepressants. Human Psychopharmacology and Clinical Experimentation 2004; 19: 353–354
   Google Scholar
• Shum S., Seale C., Hathaway D., Chucovich V., Beard D. Acute caffeine ingestion fatalities: Management issues. Veterinary and Human Toxicology 1997; 39: 228–230
   PubMedGoogle Scholar
• Sinclair C. J. D., Geiger J. D. Caffeine use in sports: A pharmacologic review. Journal of Sports Medicine and Physical Fitness. 2000; 40: 71–79
   PubMed Web of Science ®Google Scholar
• Smith A. P. Caffeine at work. Human Psychopharmacology 2005; 206: 441–445
   Google Scholar
• Sours J. A. Case reports of anorexia nervosa and caffeinism. American Journal of Psychiatry 1983; 140: 235–236
   Google Scholar
• Spriet L. L. Caffeine and performance. International Journal of Sports Nutrition 1995; 5: S84–S99, (Suppl.)
   PubMed Web of Science ®Google Scholar
• Stillner V., Popkin M. K., Pierce C. M. Caffeine-induced delirium during prolonged competitive stress. American Journal of Psychiatry 1978; 135: 855–856
   PubMed Web of Science ®Google Scholar
• Stock S. L., Goldberg E., Corbett S., Katzman D. K. Substance use in female adolescents with eating disorders. Journal of Adolescent Health 2002; 31: 176–182
   PubMed Web of Science ®Google Scholar
• Supreme Court of the Northern Territory of Australia. 2001, R v. H. File number SCC 20107499
   Google Scholar
• Warner M. A jolt of caffeine, by the can. November 23, 2005, New York Times, pp. C1, C15
   Google Scholar
• Winek C. L., Wahba W., Williams K., Blenko J., Janssen J. Caffeine fatality: A case report. Forensic Science International 1985; 29: 207–211
   PubMed Web of Science ®Google Scholar
• Wrenn K. D., Oschner I. Rhabdomyolysis induced by a caffeine overdose. Annals of Emergency Medicine 1989; 18: 94–97
   PubMed Web of Science ®Google Scholar
• Wurl P. Life-threatening caffeine poisoning by using coffee as a psychoactive drug. Wiener Klinische Wochenschrift 1994; 106: 359–361
   Google Scholar
• Zito J. M., Safer D. J., dosReis S., Gardner J. F., Magder L., Soeken K., Boles M., Lynch F., Riddle M. A. Psychotropic practice patterns for youth. Archives of Pediatric and Adolescent Medicine 2003; 157: 17–25
   PubMed Web of Science ®Google Scholar